Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee opens hearings on bills to add GLP‑1 obesity drugs to state health plans; fiscal questions remain
Summary
The House Human Services Committee opened hearings on House Bills 1451 and 1452 to add GLP‑1 anti‑obesity medications to coverage for Medicaid expansion enrollees and PERS participants. Lawmakers and health officials flagged fiscal‑note uncertainties and implementation details; both hearings were held open for further work.
The House Human Services Committee on Tuesday opened hearings on two bills that would expand coverage of GLP‑1 class anti‑obesity drugs for publicly insured North Dakotans, and left both hearings open for further work.
Representative John Nelson, sponsor of House Bills 1451 and 1452, told the committee HB1451 "would make GLP‑1 products available for anti obesity treatment to Medicaid expansion individuals." HB1452 would apply similar coverage to PERS participants and, as drafted, would operate as a two‑year pilot with a required report and an expiration date.
The bills drew technical and fiscal questions from committee members and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
